Researchers at Lund University have succeeded in preventing very early symptoms of Huntington’s disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.
“We are the first to show that it is possible to prevent the depression symptoms of Huntington’s disease by deactivating the diseased protein in nerve cell populations in the hypothalamus in the brain. This is hugely exciting and bears out our previous hypotheses”, explains Åsa Petersén, Associate Professor of Neuroscience at Lund University.
Huntington’s is a debilitating disease for which there is still neither cure nor sufficient treatment. The dance-like movements that characterise the disease have long been the focus for researchers, but the emotional problems affect the patient earlier than the motor symptoms. These are now believed to stem from a different part of the brain – the small emotional centre called the hypothalamus.
“Now that we have been able to show in animal experiments that depression and anxiety occur very early in Huntington’s disease, we want to identify more specifically which nerve cells in the hypothalamus are critical in the development of these symptoms. In the long run, this gives us better opportunities to develop more accurate treatments that can attack the mutated huntingtin where it does the most damage”, says Åsa Petersén.
The Latest Bing News on:
Huntington’s Disease
- Walkers needed for Huntington's disease 'Team Hope Walk' in Athenson April 25, 2024 at 10:37 am
The Georgia Chapter of the Huntington’s Disease Society of America is hosting a Team Hope Walk in Athens on Saturday.
- Indian-Origin Researcher Unravels Link Between Depression And Heart Diseaseon April 25, 2024 at 12:48 am
Depression and cardiovascular disease (CVD) partly develop from the same gene module, said a team of researchers establish ...
- Link between depression and cardiovascular disease explained: They partly develop from same gene moduleon April 24, 2024 at 9:20 pm
Depression and cardiovascular disease (CVD) are serious concerns for public health. Approximately 280 million people worldwide have depression, while 620 million people have CVD.
- Nanomaterial that mimics proteins could be basis for new neurodegenerative disease treatmentson April 24, 2024 at 5:00 pm
A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer's and other neurodegenerative diseases. The nanomaterial alters the interaction ...
- Anosognosia: Everything You Need to Knowon April 23, 2024 at 11:18 am
Anosognosia is a symptom in which someone lacks insight or awareness about their medical condition. It can prevent someone from recognizing they need treatment, worsening recovery outcomes. The same ...
- Labcorp, Quest add new blood tests for Alzheimer's, brain tissue damageon April 22, 2024 at 11:16 am
The twin clinical testing giants Labcorp and Quest Diagnostics have each, in the past week, added to their portfolios new blood tests that aim to peek into the workings of the human brain.
- PTC Therapeutics gets grant for treatment of huntington’s disease using compound of formula (IBBL)on April 22, 2024 at 5:22 am
Discover the latest patent from PTC Therapeutics Inc for treating Huntington's disease with innovative compounds and pharmaceutical compositions. Learn more about the groundbreaking Formula (I) and ...
- Sage halts trials in Parkinson’s after drug fails to show benefiton April 17, 2024 at 8:56 am
The Cambridge company's experimental drug was being evaluated in a Phase 2 study in people with mild cognitive impairment in Parkinson’s disease.
- Reyna’s Tacos to return to help child with rare disease — what you can doon April 17, 2024 at 8:00 am
The family of a 4-year-old San Angelo girl diagnosed with a rare neurological disease is raising funds to pay for a trip to an international conference. Here's how you can help — and walk away with a ...
- Sage burns Parkinson's bridge, flunking first of 4 midphase tests for key prospecton April 17, 2024 at 5:34 am
Sage Therapeutics has set a bad PRECEDENT for dalzanemdor. The therapy failed to improve cognitive ability in a phase 2 Parkinson’s disease study, setting Sage off on the wrong foot at the start of a ...
The Latest Google Headlines on:
Huntington’s Disease
[google_news title=”” keyword=”Huntington’s Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Huntington’s Disease symptoms
- CDC: Deer meat didn't cause hunters' deaths; concerns about chronic wasting disease remainon April 26, 2024 at 1:26 pm
There have been no cases of chronic wasting disease in people to date, the CDC says. But it is still investigating the potential risks.
- Neurocrine: Success Continues To Roll In With Positive MDD Treatment Dataon April 25, 2024 at 3:28 pm
Neurocrine achieved positive results achieved from phase 2 SAVITRI study for the treatment of patients with MDD. Check out why NBIX stock is a strong buy.
- Best organic CBG oil: benefits, side effects, and 4 products we loveon April 25, 2024 at 12:00 pm
Curious about CBG? Learn all you need to know about the cannabinoid and see the best organic CBG oil on the market.
- Link between depression and cardiovascular disease explained: They partly develop from same gene moduleon April 24, 2024 at 9:20 pm
Depression and cardiovascular disease (CVD) are serious concerns for public health. Approximately 280 million people worldwide have depression, while 620 million people have CVD.
- Anosognosia: Everything You Need to Knowon April 23, 2024 at 11:18 am
Anosognosia is a symptom in which someone lacks insight or awareness about their medical condition. It can prevent someone from recognizing they need treatment, worsening recovery outcomes. The same ...
- FDA Action Alert: ImmunityBio, Aquestive, XOMA and Moreon April 21, 2024 at 9:04 pm
The FDA will close out April with five target action dates around indications that include pediatric seizures and a neurological cancer in children.
- This Fibromyalgia Self-Care Tip Reverses Symptoms Entirely for Some Patients, MD Sayson April 19, 2024 at 7:11 am
Fibromyalgia is a chronic condition that causes widespread musculoskeletal pain and fatigue. It’s typically characterized by having at least 11 of 18 tender-to-the-touch points on both sides of the ...
- Amylyx’s Relvyvrio data was, as promised, disappointingon April 18, 2024 at 6:00 am
Amylyx Pharmaceuticals recently said it would pull its ALS drug Relyvrio from the market. After taking a look at a slide deck of data from the company’s Phase 3 PHOENIX trial, we can clearly see why.
- Sage Therapeutics stock plunges 20 percent after Parkinson’s drug fails studyon April 17, 2024 at 11:36 am
It was the latest setback for the Cambridge biotech, which in August announced it would lay off 40 percent of its workforce.
- Even mild inflammation can majorly damage the brainon April 16, 2024 at 7:30 am
A new study sheds light on how even mild inflammation can cause significant damage without directly killing the brain's neurons ...
The Latest Google Headlines on:
Huntington’s Disease symptoms
[google_news title=”” keyword=”Huntington’s Disease symptoms” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]